DANAHER Share Price NYSE
Stocks
US2358513008
Advanced Medical Equipment & Technology
| Market Cap | 146B 128B 121B 109B 205B 14,053B 207B 1,442B 556B 7,128B 550B 538B 22,883B | P/E 2026 * |
35.1x | P/E 2027 * | 28.8x |
|---|---|---|---|---|---|
| Enterprise Value | 167B 146B 138B 125B 234B 16,029B 236B 1,645B 635B 8,130B 628B 614B 26,101B | EV / Sales 2026 * |
6.34x | EV / Sales 2027 * | 5.72x |
| Free-Float |
70.45% | Yield 2026 * |
0.68% | Yield 2027 * | 0.75% |
Last Transcript: DANAHER
| 1 day | +0.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 62 | 31/08/2020 |
Matthew Gugino
DFI | Director of Finance/CFO | - | 27/02/2026 |
Steven Dee
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Spoon
BRD | Director/Board Member | 74 | 30/06/1999 |
Steven Rales
CHM | Chairman | 74 | 31/12/1983 |
Mitchell Rales
BRD | Director/Board Member | 69 | 31/12/1983 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.13% | +1.28% | - | - | 147B | ||
| +1.10% | +7.53% | +36.67% | +25.78% | 237B | ||
| -0.48% | +1.53% | +10.51% | -18.37% | 147B | ||
| +1.36% | +9.18% | -11.91% | +29.35% | 133B | ||
| +0.09% | -2.38% | -56.03% | -16.99% | 63.58B | ||
| -1.31% | -1.64% | -19.77% | -16.84% | 49.95B | ||
| +4.13% | +2.95% | +17.40% | +21.97% | 49.42B | ||
| +2.28% | +4.66% | +22.34% | +32.59% | 42.37B | ||
| +0.37% | +3.90% | +39.99% | +51.79% | 40.98B | ||
| -0.52% | +3.26% | -15.83% | +56.99% | 32.82B | ||
| Average | +0.64% | +0.67% | +2.60% | +18.47% | 88.52B | |
| Weighted average by Cap. | +0.52% | +2.43% | +8.83% | +14.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.34B 22.97B 21.75B 19.68B 36.84B 2,527B 37.16B 259B 100B 1,282B 98.92B 96.73B 4,114B | 28.45B 24.82B 23.5B 21.27B 39.8B 2,730B 40.15B 280B 108B 1,385B 107B 105B 4,445B |
| Net income | 4.2B 3.67B 3.47B 3.14B 5.88B 403B 5.93B 41.39B 15.97B 205B 15.79B 15.44B 657B | 5.15B 4.49B 4.25B 3.85B 7.2B 494B 7.26B 50.65B 19.55B 250B 19.33B 18.9B 804B |
| Net Debt | 20.6B 17.97B 17.01B 15.4B 28.81B 1,976B 29.07B 203B 78.24B 1,002B 77.37B 75.66B 3,218B | 16.19B 14.12B 13.37B 12.1B 22.65B 1,553B 22.84B 159B 61.49B 788B 60.81B 59.46B 2,529B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

















